Paper35543731
Higher accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT comparing with 2-[18F]FDG PET/CT in clinical staging of NSCLC.
Zhou X and 9 others. Eur J Nucl Med Mol Imaging, 2022. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Higher accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT comparing with 2-[18F]FDG PET/CT in clinical staging of NSCLC. Papers, record 35543731. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35543731
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Higher accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT comparing with 2-[18F]FDG PET/CT in clinical staging of NSCLC.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Fluorodeoxyglucose F18 | |
| Heterocyclic Compounds, 1-Ring | |
| Humans | |
| Positron Emission Tomography Computed Tomography | |
| Prospective Studies | |
| Quinolines | |
| Retrospective Studies |
Source PubMed
References29
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25680413 | Molecular mechanism underlying the tumor-promoting functions of carcinoma-associated fibroblasts. | Tumour Biol | 2015 | https://conductscience.org/library/papers/25680413 | PubMed |
| 2 | 29626119 | Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein. | J Nucl Med | 2018 | https://conductscience.org/library/papers/29626119 | PubMed |
| 3 | 2402505 | Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/2402505 | PubMed |
| 4 | 26200276 | A Predictive Model for Lymph Node Involvement with Malignancy on PET/CT in Non-Small-Cell Lung Cancer. | J Thorac Oncol | 2015 | https://conductscience.org/library/papers/26200276 | PubMed |
| 5 | 27089851 | Natural History of Pulmonary Subsolid Nodules: A Prospective Multicenter Study. | J Thorac Oncol | 2016 | https://conductscience.org/library/papers/27089851 | PubMed |
| 6 | 29280568 | Cancer Associated Fibroblasts: The Architects of Stroma Remodeling. | Proteomics | 2018 | https://conductscience.org/library/papers/29280568 | PubMed |
| 7 | 27550820 | The biology and function of fibroblasts in cancer. | Nat Rev Cancer | 2016 | https://conductscience.org/library/papers/27550820 | PubMed |
| 8 | 32060216 | The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience. | J Nucl Med | 2020 | https://conductscience.org/library/papers/32060216 | PubMed |
| 9 | 30072500 | 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers. | J Nucl Med | 2019 | https://conductscience.org/library/papers/30072500 | PubMed |
| 10 | 29117314 | Assessment of Fluorodeoxyglucose F18-Labeled Positron Emission Tomography for Diagnosis of High-Risk Lung Nodules. | JAMA Surg | 2018 | https://conductscience.org/library/papers/29117314 | PubMed |
| 11 | 17920724 | Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. | Lung Cancer | 2008 | https://conductscience.org/library/papers/17920724 | PubMed |
| 12 | 29626120 | A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts. | J Nucl Med | 2018 | https://conductscience.org/library/papers/29626120 | PubMed |
| 13 | 29397066 | Cancer-associated fibroblasts in tumor microenvironment - Accomplices in tumor malignancy. | Cell Immunol | 2019 | https://conductscience.org/library/papers/29397066 | PubMed |
| 14 | 34870727 | [18F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer. | Eur J Nucl Med Mol Imaging | 2022 | https://conductscience.org/library/papers/34870727 | PubMed |
| 15 | 32222810 | Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. | Eur J Nucl Med Mol Imaging | 2020 | https://conductscience.org/library/papers/32222810 | PubMed |
| 16 | 33057927 | Improved cancer detection in Waldeyer's tonsillar ring by 68Ga-FAPI PET/CT imaging. | Eur J Nucl Med Mol Imaging | 2021 | https://conductscience.org/library/papers/33057927 | PubMed |
| 17 | 27780786 | The Eighth Edition Lung Cancer Stage Classification. | Chest | 2017 | https://conductscience.org/library/papers/27780786 | PubMed |
| 18 | 31388723 | IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT. | Eur J Nucl Med Mol Imaging | 2019 | https://conductscience.org/library/papers/31388723 | PubMed |
| 19 | 34981976 | Comparison of 68Ga-FAPI and 18F-FDG PET/CT in the Evaluation of Advanced Lung Cancer. | Radiology | 2022 | https://conductscience.org/library/papers/34981976 | PubMed |
| 20 | 34272325 | Fibroblast Activation Protein-Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study. | J Nucl Med | 2022 | https://conductscience.org/library/papers/34272325 | PubMed |
Cited by39
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42667310 | [18F]FAPI-04 PET/CT for detection of recurrent breast cancer after surgery: a post hoc analysis comparing [18F]FDG PET/CT. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42667310 | PubMed |
| 42560521 | Preliminary clinical investigation of 18F-(2S,4R)-4-fluoroglutamine PET/CT in the evaluation of lung cancer. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42560521 | PubMed |
| 42196913 | Fibroblast Activation Protein Inhibitor (FAPI) PET: A Scoping Review of Emerging Oncologic and Fibroinflammatory Applications. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/42196913 | PubMed |
| 42142270 | [18F]F-FAPI PET/CT is superior to [18F]F-FDG PET/CT for lymph node staging in lung cancer: a pathologically validated study. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42142270 | PubMed |
| 41866601 | [18F]FAPI PET/CT outperforms [18F]FDG in distinguishing nodal immune flare from lymph node metastases during immunotherapy for lung cancer. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41866601 | PubMed |
| 41806020 | Diagnostic value of [68Ga]Ga-FAPI-04 PET/CT in peritoneal carcinomatosis. | Abdom Radiol (NY) | 2026 | https://conductscience.org/library/papers/41806020 | PubMed |
| 41699281 | Diagnostic performance of [18F]F-FAPI-FUSCC-07 PET/CT in characterizing solitary pulmonary nodules: a head-to-head comparison. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41699281 | PubMed |
| 41055767 | Revealing the hidden: A systematic review and meta-analysis of FAPI-based tracers imaging for brain metastatic lesions. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/41055767 | PubMed |
| 40893562 | Comparison of [68Ga]Ga-FAPI-04 and [18F]FDG PET/CT for detection of bone metastases of lung cancer. | Quant Imaging Med Surg | 2025 | https://conductscience.org/library/papers/40893562 | PubMed |
| 40805245 | Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805245 | PubMed |
| 40777126 | Comparison of [18F]AlF-NOTA-FAPI-04 PET/CT and [18F]FDG PET/CT for diagnosing lymph node metastasis in malignant tumors. | Front Oncol | 2025 | https://conductscience.org/library/papers/40777126 | PubMed |
| 40083505 | Comparison of the diagnostic accuracy between 18F-FAPI-04 PET/CT and 18F-FDG PET/CT in the clinical stage IA of lung adenocarcinoma. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/40083505 | PubMed |
| 40053176 | Insights into lung cancer diagnosis and clinical management using [18F]F-fibroblast activation protein inhibitor (FAPI)-42 positron emission tomography/computed tomography (PET/CT). | Ann Nucl Med | 2025 | https://conductscience.org/library/papers/40053176 | PubMed |
| 39760863 | [18F]F-FAPI-42 PET dynamic imaging characteristics and multiparametric quantification of lung cancer: an exploratory study using uEXPLORER PET/CT. | Eur J Nucl Med Mol Imaging | 2025 | https://conductscience.org/library/papers/39760863 | PubMed |
| 39598380 | [68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39598380 | PubMed |
| 39404790 | [68Ga]Ga-LNC1007 versus 2-[18F]FDG in the evaluation of patients with metastatic differentiated thyroid cancer: a head-to-head comparative study. | Eur J Nucl Med Mol Imaging | 2025 | https://conductscience.org/library/papers/39404790 | PubMed |
| 38937339 | Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT in diagnosing ovarian cancer. | Abdom Radiol (NY) | 2024 | https://conductscience.org/library/papers/38937339 | PubMed |
| 38872212 | Imaging at the nexus: how state of the art imaging techniques can enhance our understanding of cancer and fibrosis. | J Transl Med | 2024 | https://conductscience.org/library/papers/38872212 | PubMed |
| 38831354 | [18F]FAPI adds value to [18F]FDG PET/CT for diagnosing lymph node metastases in stage I-IIIA non-small cell lung cancer: a prospective study. | Cancer Imaging | 2024 | https://conductscience.org/library/papers/38831354 | PubMed |
| 38604763 | Diagnostic Potential of Supplemental Static and Dynamic 68Ga-FAPI-46 PET for Primary 18F-FDG-Negative Pulmonary Lesions. | J Nucl Med | 2024 | https://conductscience.org/library/papers/38604763 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35543731
GET https://conductscience.org/api/papers/v1/35543731/references?page=2